Tutti gli studi
Attivo ma non reclutanteFASE2INTERVENTISTICO

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

This research study is for people with advanced non-small cell lung cancer. It's testing different combinations of new medicines, including ones called Domvanalimab, Quemliclustat, and Zimberelimab, sometimes with existing treatments like Docetaxel. The main aim is to find out how effective these new combinations are at shrinking or controlling the cancer (this is called the 'objective response rate'). Researchers also want to understand how safe these new treatments are and what side effects they might cause. By looking at these things, the study hopes to discover better treatment options for this kind of cancer.

A colpo d'occhio

Stato
Attivo ma non reclutante
Fase
FASE2
Sponsor
Gilead Sciences
Obiettivo di iscrizione
400
Inizio
21 Feb 2023
Completamento stimato
01 Dic 2027

Di cosa tratta questo studio?

This study is exploring potential new ways to treat a type of lung cancer called advanced non-small cell lung cancer. In this study, doctors are testing different combinations of new medications, often referred to as 'immunotherapy'. Immunotherapy works by helping your body's own immune system fight the cancer cells.

The study has a few main goals. Firstly, it wants to see how well these new combinations shrink the cancer or stop it from growing. This is important for understanding if the treatments are effective. Secondly, the researchers are carefully checking the safety of these new medicine combinations. They want to know what possible side effects might occur and how well people tolerate the treatments. This will help them understand if the treatments are not only effective but also manageable for patients.

By carefully studying these new combinations, the researchers hope to find more effective and safer treatment options for people living with advanced non-small cell lung cancer. This work is a step towards improving care and offering more choices for patients in the future.

Punti chiave

  • This study evaluates new immunotherapy combinations for advanced lung cancer.
  • It aims to find effective and safe new treatment options.
  • Participation involves regular medical check-ups and monitoring.
  • You might receive new treatments not yet widely available.
  • Your health and safety are a top priority throughout the study.

Chi può essere idoneo?

To join this study, you would need to have advanced non-small cell lung cancer that has spread. Doctors would check that your general health is good enough for you to take part, and that the cancer can be measured. You would also need to be willing to provide a small sample of your tumour tissue for testing.

There are also some reasons why you might not be able to join. For example, if you have other serious health problems that the doctors think would make the study medicines unsafe for you. You also couldn't have had certain live vaccinations recently, or be taking high doses of steroid medications or other medicines that suppress your immune system just before starting the study. Certain autoimmune diseases might also prevent you from joining.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Do you have advanced non-small cell lung cancer that has spread?
  2. Is your general health good enough for you to take part?
  3. Do you have cancer that doctors can measure?
  4. Are you willing to provide a tumour tissue sample?
  5. Have you avoided live vaccines in the last 28 days?
  6. Are you taking any high-dose steroid or immune-suppressing medicines?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part in this study, you would receive one of the new medicine combinations. You would have regular visits to the clinic for check-ups, where doctors would monitor your health and how the treatment is affecting you. This would include tests like blood samples and scans to see how your cancer is responding. The doctors and nurses would also ask about any side effects you might be experiencing. The exact number of visits and tests, and the total length of time you'd be in the study, would be explained to you in detail.

Rischi e benefici potenziali

Participating in this study might offer you access to new treatments before they are widely available. While there's no guarantee the treatment will work for you, it could potentially help control your cancer. However, all medicines have potential side effects, and some of the treatments in this study are new, so not all side effects might be fully known. Your health will be closely monitored, and you can withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (53)

  • University of Alabama at Birmingham (UAB)
    Codice postale verificato
    Birmingham, Stati Uniti
  • University of California San Diego (UCSD)
    Codice postale verificato
    La Jolla, Stati Uniti
  • Memorial Cancer Institute at Memorial Regional Hospital
    Codice postale verificato
    Hollywood, Stati Uniti
  • Hematology Oncology Associates Of The Treasure Coast
    Codice postale verificato
    Port Saint Lucie, United States
  • Florida Cancer Specialists (Administration and Drug Shipment)
    Codice postale verificato
    The Villages, United States
  • Northwestern Memorial Hospital
    Codice postale verificato
    Chicago, Stati Uniti
  • Ochsner Clinic Foundation
    Codice postale verificato
    Jefferson, United States
  • Henry Ford Hospital
    Codice postale verificato
    Detroit, Stati Uniti
  • Virginia Cancer Specialists, PC
    Codice postale verificato
    Fairfax, United States
  • Medical Oncology Associated, PS (dba Summit Cancer Centers)
    Codice postale verificato
    Spokane, Stati Uniti
  • The Border Cancer Hospital
    Codice postale verificato
    Albury, Australia
  • Pindara Private Hospital
    Codice postale verificato
    Benowa, Australia

Domande comuni

What is non-small cell lung cancer?

It's the most common type of lung cancer, and 'advanced' means it has spread to other parts of the body.

Che cos'è l'immunoterapia?

Immunotherapy helps your body's own defence system fight cancer cells by boosting its ability to recognise and attack them.

What does a 'combination therapy' mean?

It means you'll be given more than one medicine at the same time, as they might work better together than alone.

Sapró quale trattamento sto ricevendo?

The study design details this. You will be fully informed before deciding to take part.

Cosa succede dopo la fine dello studio?

This will be discussed with you, but your care will always be continued by your regular medical team.

Come saperne di più

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.